ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 107 filers reported holding ENDOLOGIX INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -66.7% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $6,000 | -64.7% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $17,000 | +30.8% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $13,000 | -18.8% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $16,000 | +23.1% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $13,000 | -13.3% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $15,000 | -31.8% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $22,000 | +29.4% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $17,000 | -55.3% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $38,000 | +2.7% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $37,000 | +48.0% | 3,000 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $25,000 | -16.7% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $30,000 | -18.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $37,000 | -19.6% | 3,000 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $46,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $62,127,000 | 7.14% |
| Essex Woodlands Management, Inc. | 1,257,468 | $24,875,000 | 4.49% |
| First Light Asset Management, LLC | 304,602 | $4,673,000 | 2.20% |
| ArrowMark Colorado Holdings LLC | 3,464,775 | $53,150,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,449,897 | $37,581,000 | 1.25% |
| Iguana Healthcare Management, LLC | 200,000 | $3,068,000 | 0.97% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 82,316 | $1,262,000 | 0.71% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,651,798 | $25,339,000 | 0.64% |
| PERKINS CAPITAL MANAGEMENT INC | 34,200 | $525,000 | 0.46% |
| CADIAN CAPITAL MANAGEMENT, LP | 967,443 | $14,841,000 | 0.44% |